Takatsuka Y, Akagi K, Kawahara K, Okamura Y, Sugitachi A, Kawahara T
Dept. of Surgery, Osaka National Hospital.
Gan To Kagaku Ryoho. 1988 Aug;15(8 Pt 2):2501-4.
A Comparative study of preoperative intra-arterial infusion chemotherapy (I.A.) and transcatheter arterial chemo-embolization (TAC-E) was carried out on thirty-eight patients with locally advanced breast cancer. The results were as follows. (1) In the primary lesions, there was no difference in response rate between these two treatment modalities. (2) As for side effects, moderate myelosuppression and gastrointestinal disorders were frequently observed in I.A. group. (3) Considerably lower recurrence rate of visceral metastasis was noted in I.A. group, in comparison with the TAC-E group. After TAC-E, however, there was no local recurrence. (4) Five-year cumulative survival rate of I.A. and TAC-E group were 52.3% and 60.7% respectively, without any significant difference between the two groups. These results indicated that both I.A. and TAC-E were effective preoperative treatment for locally advanced breast cancer. Therefore, we should select each treatment modality considering the patient's characteristics.
对38例局部晚期乳腺癌患者进行了术前动脉内灌注化疗(I.A.)和经导管动脉化疗栓塞术(TAC-E)的对比研究。结果如下:(1)在原发病变中,这两种治疗方式的有效率没有差异。(2)至于副作用,I.A.组经常观察到中度骨髓抑制和胃肠道紊乱。(3)与TAC-E组相比,I.A.组内脏转移的复发率显著更低。然而,TAC-E术后没有局部复发。(4)I.A.组和TAC-E组的5年累积生存率分别为52.3%和60.7%,两组之间没有显著差异。这些结果表明,I.A.和TAC-E都是局部晚期乳腺癌有效的术前治疗方法。因此,我们应根据患者的特征选择每种治疗方式。